Standardized risk evaluation and credit scoring are crucial to advancing the cannabis industry.

CTrust Founding Member and CEO Dotan Y. Melech penned an article earlier this week in American Banker highlighting how the emergence of lending policies based on data-driven risk analyses will foster a stronger and more equitable financial landscape across the industry.

Key Insights From the American Banker article:

• No Standard Risk Analysis or Credit Scoring Methods:
  
  Adult-use cannabis has been legal for a decade, but there’s still no standard way to evaluate risk or creditworthiness in the industry.

• Rising Opportunities for Banks and Lenders:
  
  As federal restrictions loosen, emerging data-driven risk assessment methods will be key for secure and cost-effective lending in the cannabis industry.

   

• High-Risk History of Cannabis Lending:
  
  Cannabis businesses operating in over-regulated and over-taxed state markets face a difficult and unstable environment, presenting significant risks to capital.
   
• Challenges Will Persist After Federal Rescheduling: 

Financial institutions will continue to face challenges analyzing risk and managing costs since state-regulated cannabis markets will remain federally illegal. Transparent information and reliable data are essential.

Explore how CTrust’s data-driven platform and credit scoring tool work to determine the health and creditworthiness of cannabis businesses while fostering synergy, transparency and industry benchmarking between cannabis businesses and lenders.